Soft Tissue Fixation Takes A Hit In Q421

After two quarters of significant growth, Soft Tissue Fixation took a hit in Q421, with another spike in COVID cases negatively affecting procedure volumes. 2021 was a year full of ups and downs due mainly to the COVID pandemic and Q4 was no different. COVID once again brought a new wave of cases, with the Omicron variant taking its toll on Soft Tissue Fixation case volumes resulting in modest YoY revenue declines over 2020.

Among the many topics covered in detail in our comprehensive Q421 Soft Tissue Fixation Market Recap* are:

Soft Tissue Fixation Continues to Pick Up Steam in Q2 2021

With the world trying to move past the negative impacts of COVID-19, the Soft Tissue Fixation market continued to make significant advancements in the second quarter of 2021. The quarter saw a continued rise in case volumes for elective sports medicine procedures worldwide driven primarily through market recovery in the wake of the COVID-19 pandemic. 

Among the many topics covered in detail in our comprehensive Q221 Soft Tissue Fixation Market Recap* are:

Arthroscopic Technologies starts to pick up speed in 2021

While the COVID pandemic was still slowing parts of the overall medical device market, the Arthroscopic Technologies market was able to start to pull ahead as case volumes for Arthroscopic Sports Medicine procedures started to climb back towards pre-COVID levels.

Among the many topics covered in the comprehensive Q121 Soft Tissue Fixation Market Recap* are:

Despite a spike in COVID cases, Soft Tissue Fixation was resilient and managed to ride out the COVID storm in Q420

While Q4 brought another surge of COVID cases worldwide, Soft Tissue Fixation was able to weather the storm with more resilience, resulting in YoY revenue declines but sequential revenue volume improvement over Q3.

Q4 saw an increase from the previous quarter and saw numbers that closely matched the same period in 2019. According to SmartTRAK Financial Dashboard, worldwide in Q4, the Soft Tissue Fixation market was down -1.7% YoY. At the regional level, US Soft Tissue Fixation ended Q4 near even from the previous year, down -0.2%. The EU and ROW finished Q4 with declines of -2.9% and -2.8% YoY respectively.

Among the many topics covered in the comprehensive Q420/FY20 Soft Tissue Fixation Market Recap* are: